NeuroSense Therapeutics Ltd. Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments
NeuroSense Therapeutics Ltd. (NRSN) reported Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments of $3.50 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments · last filed 2024-04-04
| Period end | Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments 6 month | Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments 12 month |
|---|---|---|
| 2023-12-31 | $3.50M 20-F · filed 2024-04-04 | |
| 2023-06-30 | $3.50M 6-K · filed 2023-08-16 | |
| 2022-12-31 | -$3.50M 20-F · filed 2024-04-04 | |
| 2022-06-30 | -$6.00M 6-K · filed 2023-08-16 |